Utah monthly communicable disease report

May 2024


Background: The Utah Department of Health and Human Services collects data on over 75 communicable diseases that affect the residents of Utah. These data are monitored by epidemiologists to detect changes in disease activity and guide prevention and education efforts. More information can be found here.

Note: Individual disease investigations take time to complete; for this reason, data in this report should be considered provisional and will change as more complete reports are received.


May 2024 5-yr May avg* 2024 YTD 5-yr YTD avg*
Acute Flaccid Myelitis 0 U 0 U
Adverse event resulting from smallpox vaccination 0 0 0 0
Amebiasis 0 0 0 0
Anthrax 0 0 0 0
Arbovirus infection (not including West Nile, Dengue, or Yellow Fever) 0 0 0 0
Babesiosis 0 0 0 0
Botulism, total 0 0.2 0 1.6
Botulism, foodborne 0 0 0 0.2
Botulism, infant 0 0.2 0 1.4
Botulism, other (wound/unspecified) 0 0 0 0
Brucellosis 0 0 0 0.8
Campylobacteriosis 91 52.2 308 211.4
Chancroid 0 0 0 0
Chickenpox 8 9.4 59 49.2
Chlamydia 837 884.8 4305 4509
Cholera 0 0 0 0
Coccidioidomycosis 2 4 36 21.6
Colorado tick fever 0 1.2 0 1.4
COVID-19 1058 *** 11615 ***
Creutzfeldt-Jakob disease and other transmissible human spongiform encephalopathies 0 0.2 3 1.6
Cryptosporidiosis 17 15.4 71 68.8
Cyclosporiasis 4 3.2 4 4.2
Dengue 1 0.2 8 1
Diphtheria 0 U 0 U
Echinococcosis 0 0 0 0
Ehrlichiosis/Anaplasmosis 0 0 0 0
Encephalitis 0 0.4 1 1
Giardiasis 19 16.2 84 67
Gonorrhea 180 234.2 806 1197.8
HIV infection 21 8.6 95 51.8
Haemophilus influenzae, all ages, invasive disease 12 3.4 45 19
nonserotype B, age <5 years 0 0.2 0 2.2
serotype B, age <5 years 0 0 0 0
unknown serotype, age <5 years 0 0 0 0.6
Hansen’s disease (Leprosy) 0 0.2 0 0.6
Hantavirus infection 0 0 0 0.2
Hemolytic uremic syndrome, post-diarrheal 1 0.2 4 1.4
Hepatitis A 0 2 2 7.4
Hepatitis B, acute 2 2.2 5 7.4
Hepatitis B, chronic 7 5.6 46 32
Hepatitis C, acutea 12 18.4 57 88.4
Hepatitis C, chronicb 105 109 458 550.8
Hepatitis, other viral 0 0.2 0 0.2
Influenza-associated hospitalization 28 32.6 961 778
Influenza-associated pediatric mortality 0 0 3 1.2
Legionellosis 2 3.6 13 11.4
Leptospirosis 0 0.2 1 0.8
Listeriosis 0 U 1 U
Lyme disease 2 1 6 3.2
Malaria 0 0.8 11 3.2
Measles 0 0 0 0.2
Meningitis, aseptic 0 0.6 0 2.4
Meningitis, bacterial, other 0 0.6 8 6.6
Meningitis, viral 5 1.2 25 7.4
Meningococcal Disease (Neisseria meningitidis) 1 0.2 1 0.8
Mumps 1 0.8 3 4.6
Pertussis 10 24.8 62 93
Plaguec 0 0 0 0
Poliomyelitis, paralytic and nonparalytic 0 0 0 0
Psittacosis 0 0 0 0
Q fever 0 0.6 1 2.2
Rabies, animal 0 0.4 0 0.4
Rabies, human 0 0 0 0
Relapsing fever, tick-borne and louse-borne 0 0 0 0
Rubella 0 0 2 0
Rubella, congenital syndrome 0 0 0 0
Salmonellosis 42 30.6 174 119.2
Severe Acute Respiratory Syndrome (SARS) 0 0 0 0
Shiga toxin-producing Escherichia coli (STEC) infection 20 18.6 88 67.2
Shigellosis 10 8 54 34.4
Smallpox 0 0 0 0
Spotted fever rickettsiosis (including Rocky Mountain Spotted Fever) 1 0 2 0.4
Streptococcal disease, invasive, group A 21 21 157 116.2
Streptococcal disease, invasive, group B 18 21.8 84 99.6
Streptococcal disease, invasive, other 8 28.8 16 168
Streptococcus pneumoniae, invasive disease 17 17.4 110 91.8
age <5 years 2 1 13 5.6
Syphilis, congenital 0 0 0 0
Syphilis, early (infection < 12 months) 23 18.2 121 79.6
primary & secondary 23 18.2 121 79.6
early latent 0 0 0 0
Syphilis, latent (infection > 12 months) 0 0 0 0
Tetanus 0 0 0 0
Toxic shock syndrome (staphylococcal or streptococcal) 1 3.2 12 16.4
Trichinellosis 0 0 0 0
Tuberculosis, active 6 2 24 10
Tularemia 0 0 0 0.2
Typhoid fever 0 0.4 0 1.4
Vancomycin-intermediate Staphylococcus aureus (VISA) 0 0 0 0
Vancomycin-resistant Staphylococcus aureus (VRSA) 0 0 0 0
Vibriosis 2 1.2 14 3.8
Viral hemorrhagic fevers 0 0 0 0
West Nile virus, total 0 0 0 0
Yellow fever 0 0 0 0
Zika Virus Disease 0 U 0 U
Note:
U: 5-yr average is unavailable (U) because of changes in communicable disease reporting rules.
a In 2019, the DHHS began reporting only confirmed cases of acute Hepatitis C. Previously, the DHHS reported confirmed and probable cases. The 5 year averages presented here represent only confirmed cases in the past 5 years.
b In 2019, the DHHS began reporting only confirmed cases of chronic Hepatitis C. Previously, the DHHS reported confirmed and probable cases. The 5 year averages presented here represent only confirmed cases in the past 5 years.
c In 2019, the DHHS began reporting only confirmed cases of plague. Previously, the DHHS reported confirmed and probable cases. The 5 year averages presented here represent only confirmed cases in the past 5 years.
* Averages are susceptible to skewing due to outbreaks and should be interpreted with care.
YTD indicates counts are year-to-date.